| Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer WR Lee, JJ Dignam, MB Amin, DW Bruner, D Low, GP Swanson, ... Journal of Clinical Oncology 34 (20), 2325-2332, 2016 | 644 | 2016 |
| Importance of normalization of CA19-9 levels following neoadjuvant therapy in patients with localized pancreatic cancer S Tsai, B George, D Wittmann, PS Ritch, AN Krepline, M Aldakkak, ... Annals of surgery 271 (4), 740-747, 2020 | 186 | 2020 |
| The transformation of radiation oncology using real-time magnetic resonance guidance: A review WA Hall, ES Paulson, UA van der Heide, CD Fuller, BW Raaymakers, ... European Journal of Cancer 122, 42-52, 2019 | 183 | 2019 |
| Radiation therapy for pancreatic cancer: executive summary of an ASTRO clinical practice guideline M Palta, D Godfrey, KA Goodman, S Hoffe, LA Dawson, D Dessert, ... Practical radiation oncology 9 (5), 322-332, 2019 | 175 | 2019 |
| A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer H Nasief, C Zheng, D Schott, W Hall, S Tsai, B Erickson, X Allen Li NPJ precision oncology 3 (1), 25, 2019 | 146 | 2019 |
| Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation J Zhong, K Patel, J Switchenko, RJ Cassidy, WA Hall, T Gillespie, ... Cancer 123 (18), 3486-3493, 2017 | 136 | 2017 |
| Pronecrotic mixed lineage kinase domain‐like protein expression is a prognostic biomarker in patients with early‐stage resected pancreatic adenocarcinoma LE Colbert, SB Fisher, CW Hardy, WA Hall, B Saka, JW Shelton, ... Cancer 119 (17), 3148-3155, 2013 | 135 | 2013 |
| Use of total neoadjuvant therapy for locally advanced rectal cancer: initial results from the pembrolizumab arm of a phase 2 randomized clinical trial OE Rahma, G Yothers, TS Hong, MM Russell, YN You, W Parker, ... JAMA oncology 7 (8), 1225-1230, 2021 | 128 | 2021 |
| NRG oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer WA Hall, E Paulson, BJ Davis, DE Spratt, TM Morgan, D Dearnaley, ... International Journal of Radiation Oncology* Biology* Physics 109 (1), 174-185, 2021 | 117 | 2021 |
| Validation of a 22-gene genomic classifier in patients with recurrent prostate cancer: an ancillary study of the NRG/RTOG 9601 randomized clinical trial FY Feng, HC Huang, DE Spratt, SG Zhao, HM Sandler, JP Simko, ... JAMA oncology 7 (4), 544-552, 2021 | 115 | 2021 |
| Postoperative radiotherapy is associated with better survival in non–small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base JL Mikell, TW Gillespie, WA Hall, DC Nickleach, Y Liu, J Lipscomb, ... Journal of Thoracic Oncology 10 (3), 462-471, 2015 | 113 | 2015 |
| Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head-and-neck cancer undergoing initial surgical resection RS Prabhu, KR Magliocca, S Hanasoge, AH Aiken, PA Hudgins, WA Hall, ... International Journal of Radiation Oncology* Biology* Physics 88 (1), 122-129, 2014 | 112 | 2014 |
| 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience ES Paulson, E Ahunbay, X Chen, NJ Mickevicius, GP Chen, C Schultz, ... Clinical and translational radiation oncology 23, 72-79, 2020 | 106 | 2020 |
| Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study X Chen, K Oshima, D Schott, H Wu, W Hall, Y Song, Y Tao, D Li, C Zheng, ... PloS one 12 (6), e0178961, 2017 | 96 | 2017 |
| Stereotactic body radiosurgery for spinal metastatic disease: an evidence‐based review WA Hall, LJ Stapleford, CG Hadjipanayis, WJ Curran, I Crocker, HKG Shu International journal of surgical oncology 2011 (1), 979214, 2011 | 96 | 2011 |
| Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline–directed treatment for stage II and III disease A Kolarich, TJ George Jr, SJ Hughes, D Delitto, CJ Allegra, WA Hall, ... Cancer 124 (17), 3510-3519, 2018 | 94 | 2018 |
| Association of presalvage radiotherapy PSA levels after prostatectomy with outcomes of long-term antiandrogen therapy in men with prostate cancer RT Dess, Y Sun, WC Jackson, NK Jairath, AU Kishan, DG Wallington, ... JAMA oncology 6 (5), 735-743, 2020 | 90 | 2020 |
| The MOMENTUM study: an international registry for the evidence-based introduction of MR-guided adaptive therapy SR de Mol van Otterloo, JP Christodouleas, ELA Blezer, H Akhiat, ... Frontiers in Oncology 10, 1328, 2020 | 89 | 2020 |
| Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians WA Hall, E Paulson, XA Li, B Erickson, C Schultz, A Tree, M Awan, ... CA: a cancer journal for clinicians 72 (1), 34-56, 2022 | 86 | 2022 |
| ADC measurements on the Unity MR-linac–A recommendation on behalf of the Elekta Unity MR-linac consortium ES Kooreman, PJ van Houdt, R Keesman, FJ Pos, VWJ van Pelt, ... Radiotherapy and Oncology 153, 106-113, 2020 | 85 | 2020 |
Nick PaulsonProfessor, University of Illinois at Urbana-ChampaignVerified email at illinois.edu
